ARS Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
SPRY chart
What traders are saying about $SPRY
Latest postsARS Pharmaceuticals, Inc. news
- Form 144 ARS PHARMACEUTICALS For: 9 November By Investing.com
Investing.com Canada ·
- Officer Eric Karas proposes a $402K share sale at ARS Pharmaceuticals (SPRY).
Stock Titan ·
- Weekly Recap: Revenue misses estimates and Raymond James downgrades
TradingView ·
- ARS Pharmaceuticals Analysts Cut Their Forecasts After Downbeat Q3 Results
Benzinga ·
- Raymond James downgrades ARS Pharmaceuticals to Outperform from Strong Buy, lowers price target to $17
TradingView ·
- Raymond James downgrades ARS Pharmaceuticals stock rating on weak sales
Investing.com ·
- ARS Pharmaceuticals Inc (SPRY) Q3 2026 Earnings Call Highlights: neffy Market Share Tops 5% as ...
Yahoo Finance ·
- ARS Pharmaceuticals (NasdaqGM:SPRY) Stock Forecast & Analyst Predictions
Simply Wall St ·
- ARS Pharmaceuticals (SPRY) Institutional Ownership 2026 $SPRY
MarketBeat ·
- ARS Pharmaceuticals Q3 Earnings Call Highlights
marketbeat.com ·
- ARS Pharmaceuticals earnings missed by $0.06, revenue fell short of estimates
Investing.com Canada ·
- ARS Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
ARS Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $84.3M | $89.1M | $30,000 | $1.3M |
| Net income | -$171.3M | $8.0M | -$54.4M | -$34.7M |
| Diluted EPS | $-1.74 | $0.08 | $-0.57 | $-0.87 |
| Total assets (year end) | $327.7M | $351.2M | $233.2M | $281.4M |
| Cash and equivalents (year end) | $41.3M | $50.8M | $71.0M | $210.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ARS Pharmaceuticals, Inc.
- Ticker
- SPRY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1671858
- Former names
- Silverback Therapeutics, Inc.
Frequently asked questions
What exchange is ARS Pharmaceuticals, Inc. listed on?
ARS Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SPRY.
What industry is ARS Pharmaceuticals, Inc. in?
ARS Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is ARS Pharmaceuticals, Inc. headquartered?
ARS Pharmaceuticals, Inc.'s business address on file with the SEC is in San Diego, CA.
When does ARS Pharmaceuticals, Inc.'s fiscal year end?
ARS Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did ARS Pharmaceuticals, Inc. report?
ARS Pharmaceuticals, Inc. reported $84.3M in revenue for calendar year 2025, according to its SEC filings.